Episode 3: Antibody Biopolymer Conjugates for Ophthalmology
A view on - Een podcast door Lonza
Categorieën:
Bridging Business and Biotechnology: Kodiak Sciences Is Increasing Treatment Efficacy for Retinal Diseases Victor Perlroth, MD, the Chairman and CEO of Kodiak Sciences, discusses how the company’s ABC platform medicines are designed to treat the leading causes of blindness.
